The URL can be used to link to this page

Home My WebLink About062223 Pinpointing pain_ Is it cancer or cancer treatment_________________________________ ALERT: BE CAUTIOUS This email originated outside the organization. Do not open attachments or click on links if you are not expecting them. ________________________________ Cancer pain side effects | ASCO 2023 highlights | Hurvitz to lead Clinical Research ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ View as Web page <https://secure.fredhutch.org/site/R?i=3TCvRn-gnDWvnuK1zsCtqzk5bb9F4hs4BeGV3lfxq7-FsexkKNq4Ig> <https://secure.fredhutch.org/site/R?i=JG6blOWEEbS0ZFtkRzE4Bmfr6til0Zo_1dLUINDz_j36fOPfc_kX2g> <https://secure.fredhutch.org/images/content/pagebuilder/fhcc-eml-hdr-shadow.png> <https://secure.fredhutch.org/site/R?i=mXyQtBJwnxm19FI0AnBxBNFtBD-86l5Ica_cBbjXoG3bLxcC1c0eGA> June 22, 2023 ⋅ A monthly digest of the latest from Fred Hutch Distinguishing side effects of cancer treatment from a potential recurrence can be tricky; Experts offer advice <https://secure.fredhutch.org/site/R?i=vLRBK46eaCyASRkA-WBfxFiiYAO9jFqJ685e0mLM4uaJD0hn u4SE9w> After treatment for cancer, oncologists generally send you home with a slew of surveillance appointments and a reminder to reach out should you happen to notice any symptoms that are new and different. The only problem? Your body’s been through the mill. Everything feels new and different. Weird aches and pains abound after cancer treatment, making it hard for patients in remission to figure out whether they’re suffering a treatment side effect or experiencing the first whispers of a cancer recurrence. Most early-stagers know that even after systemic (or system-wide) treatments like chemotherapy and/or anti-hormones, their cancer can become metastatic, spreading from its original site to organs like the lungs, liver or brain, and triggering pain, shortness of breath, headaches and other symptoms. They also know cancer treatment can cause all manner of collateral damage. What they often don’t know is how to tell one from the other. We turned to cancer patients and Fred Hutch clinicians for answers on how to discern between pain and symptoms <https://secure.fredhutch.org/site/R?i=NyYu3DpF8TWyctt1-G21Qkb-Pf_IAO72NYOBQrpIjm7u8GvXW GdvGg> that are “normal” after treatment from those that need to be evaluated by your cancer surgeon, oncologist or primary care physician. ________________________________ Public Art and Community Dialogue <https://secure.fredhutch.org/site/R?i=g7QL9ju1rM-3yD0_NkCokzZwAxhwK_iyR2hMEE-EQtAav71b9DpjAg> On June 1, Fred Hutch celebrated the start of Pride month by unveiling the fourth art installation as part of our Public Art & Community Dialogue Program <https://secure.fredhutch.org/site/R?i=twKliY zH9_FNlNTm8qwV55uvqZ08bMgz4xDZJKyHMJqXyNSzKYY9iw> , featuring artwork “Block #3249 (Mend)” by artist Ariadne Campanella. ________________________________ The Latest Dr. Sara Hurvitz joins Fred Hutch, University of Washington <https://secure.fredhutch.org/site/R?i=fWvpo7TM9Uiw-UAmqzHjqse2i0DZ7gZATOvWiuk68uj7-xb552hl7w> The organizations announced the hiring of Sara Hurvitz, MD, as the Senior Vice President of the Clinical Research Division at Fred Hutch and Head of the newly united Division of Hematology and Oncology at the University of Washington Department of Medicine. ASCO 2023 highlights: Fine-tuning cancer care <https://secure.fredhutch.org/site/R?i=mgzAeEGL_3dwrV3wt4_rFYg_Q6fgNYOGue178CR2yIdv18vt_ly-8g> The annual meeting of the American Society of Clinical Oncology, held each year in Chicago, has wrapped up with a staggering array of new scientific insights for cancer patients, caregivers and clinicians, including less-toxic treatments, more precision oncology and new ways to reduce collateral damage. Navigating a cancer diagnosis while pregnant <https://secure.fredhutch.org/site/R?i=oYwYDl1BITFVyQXNBkwXqFHH8sgVvxT4uXXQ_zUCqYVWSWwORPREsg> A woman pregnant with her second child received a cancer diagnosis after an elevated level of a particular protein led to additional genetic tests. The finding of a particular genetic mutation, DICER1, solved a puzzle in her life and led to ongoing surveillance of her two children as well. A promising HIV vaccine candidate gets a little help <https://secure.fredhutch.org/site/R?i=QeZJ-wEfKcNdtOQAz_pleKZ0LDJaabfbAdsdC6M0_UZP47GOuqkKRw> In the 40-year effort to develop a vaccine for HIV/AIDS, hardworking scientists could use some help. New research suggests they may have found some in the form of a common white blood cell called a CD4 T lymphocyte — also known, incidentally, as a helper T cell — that could play a crucial role in a bold and complex new strategy for making an effective HIV/AIDS vaccine. 3rd Annual DEI Summit looks to the future <https://secure.fredhutch.org/site/R?i=RCxWMEpE57mailadN60BhJxL7xTVo5qKPJnqumcV4r4vatXg6Rv2FA> In early June, representatives from across Fred Hutch met at the organization’s third annual Diversity, Equity & Inclusion Summit, Integrating Critical Change for Critical Cures. The 2023 symposium offered the opportunity for participants to take stock of past progress, and gain inspiration for future progress, as the organization builds on the promise and potential offered by a fully integrated cancer center. ________________________________ Good News Virus researchers Cohn and Blanco-Melo win coveted grants <https://secure.fredhutch.org/site/R?i=ndrh-z3zZLOWUvn897DmEdyCt4SANLcmAeh5QuB63rPx-8qGgmP8Kw> Lillian Cohn, PhD, was named by the Pew Charitable Trusts as one of 22 members of this year’s class of biomedical scholars, a program that includes an award to support her research over the next four years. Daniel Blanco-Melo, PhD, is about to begin his first year as one of 15 new Searle scholars, a similarly sought-after honor supported by the Searle Funds at the Chicago Community Trust. McGarry Houghton receives Satya and Rao Remala Family Endowed Chair <https://secure.fredhutch.org/site/R?i=AHXn2RolCOmHItfOdS3JbBzP-X26DQsUbcziSWCDebN0BTMNldcPRQ> McGarry Houghton, MD, a pulmonary physician-scientist whose work explores the immune system’s role in cancer and lung cancer early detection, has been named the first recipient of the Satya and Rao Remala Family Endowed Chair at Fred Hutchinson Cancer Center. Grants to foster health equity in Washington <https://secure.fredhutch.org/site/R?i=nfR_h_Q9C-g29bMEc_i9mjfrdLgzUTFWcUaRFrPEyLdY8b3uHMOjig> Nine community-driven organizations will receive support from Fred Hutch’s Community Grants Program to improve outcomes for underrepresented residents across the state. ________________________________ <https://secure.fredhutch.org/site/R?i=2Z8msy4bIvU-VCJ_KPkIaLLjVSnZfau6gMA7wTBO2iBuRj4HuDiCWg> Don't Miss Fred Hutch Obliteride! Fred Hutch Obliteride is a summer bike ride and 5K that empowers people to help cure cancer faster by raising funds for Fred Hutchinson Cancer Center. <https://secure.fredhutch.org/site/R?i=1Y0Ku3otchr69UmuTVAPeFgMWnY9w-z12WytlhdoQDju6DvJFxwRDg> ________________________________ Share this newsletter with family or friends <https://secure.fredhutch.org/site/R?i=x_mCpj96Wxey5jpr1FqtvR9b1M1aeXemC0Ho8crXHWImhGtwnonWtQ> <https://secure.fredhutch.org/site/R?i=NTDjBKbGAbg7R5NE-jeVff4xcrHop3gHHtCN46CwssnZLZGkGyeeAA> 1100 Fairview Ave. N., Seattle, WA 98109 communications@fredhutch.org <mailto:communications@fredhutch.org> 206.667.5000 <https://secure.fredhutch.org/site/R?i=42_8r-rKLUdCpQgFb69ZTHWOKDC5eO2XElRJr0sVf9WVB_-37B8zEA> <https://secure.fredhutch.org/site/R?i=NdGN_luR4fL7iPHsaQTcqZtlw9ohnS8R0Hvj7dTsqpdQmhRaYpDAlg> <https://secure.fredhutch.org/site/R?i=WecHgb1Ul2TQ9gzevBU3K3vazZ3CLwViEZ83lPDWxZnglr5Ax-TpWA> <https://secure.fredhutch.org/site/R?i=xtg8mLaL1RfNZkQdKBn6clxdIuAmNd1yalwzJtmd6umF-bXc6FsaDQ> ________________________________ Fred Hutchinson Cancer Center is a 501(c)(3) nonprofit organization. You can adjust your email preferences <http://engage.fredhutch.org/site/CO?i=7hta8nz8PViQyISiuerzMFtPsBo2IlOses5WyY0vw-a5w-sCwboCDxayMyBbn5yz&cid=1021> at any time or contact us at optout@fredhutch.org <mailto:optout@fredhutch.org> to be removed from both mail and email lists. For information about our privacy practices, see our Privacy Policy <https://secure.fredhutch.org/site/R?i=f7p4uU0YVw8qRYzwGcVRndY2FJd7DJoW2ZKN83t5MmMJFCcVrO6weg> . © 2023 Fred Hutchinson Cancer Center. All rights reserved. <http://engage.fredhutch.org/site/PixelServer?j=X1tCRhyG2URHpinIIJr_6LlpcA5Bs29lEgTbREsQhToy92OjFkmEqQ> DMBAF77K1i/1Yu8++SkghRxJujIuoCATfPSqc5jEMzH t8qX46rdTHTnS+aQ3wMmgfMokAMZtsFs1rcW0owq+S4cxJ6Jr+/d6Pu9dw8/tApWJDK8 whOTUsoaxWc+Skhtnoev4AGV7FD4IAAAA= X-BESS-Spam-Status: SCORE=0.00 using global scores of QUARANTINE_LEVEL=N/A KILL_LEVEL=5.0 tests=HTML_MESSAGE Received-SPF: pass (mx-inbound10-94.us-east-2a.ess.aws.cudaops.com: domain of email_feedback_handler@bbcsreturn.convio.net designates 216.235.195.38 as permitted sender) X-BESS-Spam-Report: Code version 3.2, rules version 3.2.2.249009 [from cloudscan14- 164.us-east-2a.ess.aws.cudaops.com] Rule breakdown below pts rule name description ---- ---------------------- -------------------------------- 0.00 HTML_MESSAGE BODY: HTML included in message X-BESS-Spam-Score: 0.00 X-BESS-BRTS-Status: 1 X-MS-Exchange-Organization-Network-Message-Id: b8c343e1-8f0c-4cc7-6272-08db7378a52c X-MS-Exchange-Organization-AuthSource: mail2013ca1.internal.county.domain X-MS-Exchange-Organization-AuthAs: Anonymous